Evidence map›Paper›PMID 30388619›Full record

ArticleMolecular therapy. Nucleic acids2018

Astrocyte EV-Induced lincRNA-Cox2 Regulates Microglial Phagocytosis: Implications for Morphine-Mediated Neurodegeneration.

Guoku Hu, Ke Liao, Fang Niu, Lu Yang, Blake W Dallon, Shannon Callen, Changhai Tian, Jiang Shu, Juan Cui, Zhiqiang Sun and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Role of microRNAs in the pathophysiology of addiction.Wiley interdisciplinary reviews. RNA · 2021
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Guoku HuDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. Electronic address: guoku.hu@unmc.edu.
Ke LiaoDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Fang NiuDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Lu YangSchool of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China.
Blake W DallonDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Shannon CallenDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA.
Changhai TianDepartment of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE 68198-5850, USA.
Jiang ShuDepartment of Computer Science and Engineering, University of Nebraska-Lincoln, Lincoln, NE, USA.
Juan CuiDepartment of Computer Science and Engineering, University of Nebraska-Lincoln, Lincoln, NE, USA.
Zhiqiang SunDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198-6025, USA.
Yuri L LyubchenkoDepartment of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE 68198-6025, USA.
Minhan KaCenter for Substance Abuse Pharmacology, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea.
Xian-Ming ChenDepartment of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, NE, USA.
Shilpa BuchDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5880, USA. Electronic address: sbuch@unmc.edu.
University of Nebraska Medical Center · USUniversity of Nebraska–Lincoln · USCreighton University · USKorea Institute of Toxicology · KRUniversity of Electronic Science and Technology of China · CN

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latencyR01DA041751 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J., BYRAREDDY, SIDDAPPA N · 2016 to 2020
$3.9M
The brain as a SIV reservoir under suppressive cART potentiation by drugs of abuseR01DA043164 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J., BYRAREDDY, SIDDAPPA N · 2016 to 2020
$3.8M
HIV Tat & Morphine induce mircroglial migration & activation via release of miR-9 & 138R01DA040397 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J., FOX, HOWARD S · 2015 to 2019
$2.5M
HIV-1 mediated synaptodendritic injury and microglial activation: Role of extracellular vesicle miRNAsR01MH112848 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J., HU, GUOKU · 2017 to 2021
$2.1M
HIV Tat & cocaine-mediated alterations in microglial migration & activation involve epigenetic reulation of miRNAsR01DA043138 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BUCH, SHILPA J., GUO, MINGLEI · 2016 to 2020
$1.9M
Intranasal delivery of exosomes loaded with miRs -223 and -124 as a therapeutic strategy for HAND in cocaine usersR21DA046831 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CHIVERO, ERNEST, GURUMURTHY, CHANNABASAVAIAH · 2018 to 2019
$419k
Exosome-mediated anti-microRNA delivery into the CNS: A Novel Threpautic for HAND in opiate usersR21DA042704 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GUO, MINGLEI, HU, GUOKU · 2017 to 2018
$414k
NIDA NIH HHS R01 DA040397NIDA NIH HHS R01 DA041751NIDA NIH HHS R01 DA043138NIDA NIH HHS R01 DA043164NIDA NIH HHS R21 DA042704NIDA NIH HHS R21 DA046831NIMH NIH HHS P30 MH062261NIMH NIH HHS R01 MH112848
6 · The paper itself

Abstract

Impairment of microglial functions, such as phagocytosis and/or dysregulation of immune responses, has been implicated as an underlying factor involved in the pathogenesis of various neurodegenerative disorders. Our previous studies have demonstrated that long intergenic noncoding RNA (lincRNA)-Cox2 expression is influenced by nuclear factor κB (NF-κB) signaling and serves as a coactivator of transcriptional factors to regulate the expression of a vast array of immune-related genes in microglia. Extracellular vesicles (EVs) have been recognized as primary facilitators of cell-to-cell communication and cellular regulation. Herein, we show that EVs derived from astrocytes exposed to morphine can be taken up by microglial endosomes, leading, in turn, to activation of Toll-like receptor 7 (TLR7) with a subsequent upregulation of lincRNA-Cox2 expression, ultimately resulting in impaired microglial phagocytosis. This was further validated in vivo, wherein inhibition of microglial phagocytic activity was also observed in brain slices isolated from morphine-administrated mice compared with control mice. Additionally, we also showed that intranasal delivery of EVs containing lincRNA-Cox2 siRNA (small interfering RNA) was able to restore microglial phagocytic activity in mice administered morphine. These findings have ramifications for the development of EV-loaded RNA-based therapeutics for the treatment of various disorders involving functional impairment of microglia.

Indexed as

CNSdrug abuseexosomeextracellular vesiclelincRNAmicrogliamorphinephagocytosis

Identifiers

PMID30388619
PMCPMC6202788
OpenAlexW2892516612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.